Dr. Amy Sanford, an oncologist with Sanford discusses the findings of a new study that shows greater survival for newly diagnosed advanced lung cancer patients who receive an immunotherapy drug plus standard chemotherapy. These results are expected to change the way patients are treated.
Innovation: Dr. Amy Sanford
